LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Next-Generation Hemoglobin Analyzer Uniquely Ensures Bi-Directional Data Management Future Proofing

By LabMedica International staff writers
Posted on 04 May 2015
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
Image: The new point-of-care Hemo Control delivers laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely offers flexible and enhanced data management with bi-directional interface (Photo courtesy of EKF Diagnostics).
A new point-of-care (POC) diagnostics analyzer delivers quantitative laboratory-accurate hemoglobin and hematocrit results in one simple test and uniquely enables upgrade with data management functionality as required, giving broad flexibility over future connectivity options via its bi-directional interface.

The new robust, portable Hemo Control from EKF Diagnostics (Cardiff, UK) provides accuracy and reliability of results (imprecision of <2%) from 25 seconds for blood banks, hospitals, and clinics. It can easily communicate with in-house systems: using the new LIS2-A2 communication standard, this bi-directional interface allows the analyzer to connect directly to third party software and enable simple integration with LIS (Laboratory Information System) middleware. (LIS2-A2 succeeds the ASTM communication standard commonly used for small to mid-size analyzers and is easier to integrate than POCT-1A.)

This cost-effective basic device stores up to 4,000 patient results and offers enhanced on-board Data Management (DM) functions following upgrade with the DM “add pack” if required at a later date. In addition to enabling lists to be sent directly from the LIS to Hemo Control, DM upgrade also offers barcode identification of patients, operators, cuvette LOT and control materials, as well as quality control with lock-out functions and ability to add comments to results. Hemo Control requires no docking station when handling on-board data management as it uses simple cable connections (e.g. RS-232 to USB or LAN), or integrated Bluetooth technology available with Hemo Control Manager—the top-of-the-range device available with preinstalled DM functions.

“Our new Hemo Control with flexible DM upgrade and bi-directional connectivity is ideal for customers who wish to keep their connectivity options open. This may be because they are planning on future connection of POC devices to the LIS but have yet to decide, or they may need to split costs for budgetary reasons by upgrading at a later date,” said Katja Lemburg, global product manager for hematology.

This compact analyzer is user friendly with step-by-step on-screen instructions, needs no calibration or maintenance, and requires minimal user training. Furthermore, Hemo Control uses NXT shape microcuvette technology, which enables improved finger stick sample collection by virtually eliminating appearance of air bubbles.

Related Links:

EKF Diagnostics
Hemo Control with “Add Pack” options



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Sample Transportation System
Tempus1800 Necto

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more